Stereotaxis is trading 5.69% down at $0.99 on November 6, 2026; no company-specific announcement explaining the decline was identified.
- The latest listed release was November 2, and third-quarter results are scheduled for November 10.
- Healthcare stocks are also lower, with XLV down 1.48% during the regular session. This provides sector context but does not establish a company-specific catalyst.